Skip to content

Author

Alperen Akansel Çağlar

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Prognostic Value of the Lung Immune Prognostic Index in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab: A Real-World Analysis Beyond PD-L1 Expression

Background: The Lung Immune Prognostic Index (LIPI), based on the derived neutrophil-to-lymphocyte ratio and lactate dehydrogenase, may reflect systemic inflammation and tumor-related metabolic burden. This study evaluated the prognostic value of pretreatment LIPI and its relationship with programmed death-ligand 1 (PD...

Alperen Akansel Çağlar, A. Özmen, T. B. Genç et al. · 0 citations
Open access Aug 2026

Adjuvant chemotherapy patterns and clinicopathological factors associated with survival in patients aged 70 years and older with resected stage II–III colon cancer: a single-center real-world study

Aims: Older adults are underrepresented in adjuvant colon cancer trials, leaving uncertainty regarding oxaliplatin benefit and optimal treatment duration. This study evaluated the associations of adjuvant chemotherapy patterns, treatment duration, and clinicopathological factors with overall survival (OS) and disease-f...

Zekeriya Hannarici, A. Turhan, M. E. Büyükbayram et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.